Rifampin and Hormonal Contraceptives Interaction

Introduction to the Interaction

The Centers for Disease Control and Prevention (CDC) recommends that women using hormonal birth control should be advised to add or switch to a barrier method when taking rifampin, as rifampin substantially decreases the effectiveness of hormonal birth control, including Nikki, by inducing drug-metabolizing enzymes that accelerate the breakdown of ethinyl estradiol and progestins in the body 1, 2, 3

The interaction between rifampin and combined oral contraceptives is classified as Category 3 by the CDC Medical Eligibility Criteria, meaning the risks of using combined oral contraceptives with rifampin usually outweigh the benefits 3
The CDC guidelines explicitly state that women using hormonal birth control should be advised to add or switch to a barrier method when taking rifampin, based on evidence from studies that demonstrate rifampin significantly decreases both ethinyl estradiol and norethindrone exposure, with increases in follicle-stimulating hormone levels indicating reduced contraceptive suppression 4, 5, 6

The CDC recommends using condoms consistently during rifampin therapy and for at least one full menstrual cycle after completing treatment, as a simple approach for short-term rifampin treatment 1
Switching to a non-hormonal method, such as a copper IUD, is preferred for long-term rifampin therapy, as it is unaffected by rifampin and provides highly effective contraception 4
Injectable contraception (DMPA/Depo-Provera) is classified as Category 1 with rifampin, meaning its effectiveness is not decreased by rifampin, and is a viable alternative for women who prefer to continue hormonal contraception 1

The duration of rifampin treatment matters, as even short courses can significantly reduce contraceptive hormone levels and increase ovulation markers, and backup contraception should be continued for at least one full cycle after stopping rifampin 5, 6
All hormonal methods, including pills, patches, rings, and implants, are affected by the interaction, except for DMPA injections, which maintain effectiveness with rifampin 1, 2, 3

Rifampin is a potent inducer of hepatic cytochrome P450 enzymes that accelerates the metabolism of estrogen and progestins, reducing their systemic exposure and contraceptive efficacy, as reported by the American Thoracic Society 7

All estrogen-progestin combinations are affected, including combined oral contraceptives, transdermal patches, and vaginal rings, which rely on hormones metabolized by the same enzyme pathways that rifampin induces, according to the American Academy of Pediatrics 8
Progestin-only methods, such as etonogestrel implants, progestin-only pills, and levonorgestrel IUDs, are also compromised by rifampin, which induces metabolism of all progestins, as stated by the Centers for Disease Control and Prevention 9

Rifampin is unique among antibiotics, with extensive literature reviews finding no definitive evidence of decreased contraceptive effectiveness with any antibiotic except rifampin, as noted by the American Academy of Pediatrics 8